Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Synopsis

Clinical Features and Comparison of Kingella and Non–Kingella Endocarditis in Children, Israel

On This Page
Methods
Results
Discussion
Cite This Article
Tables
Table 1
Table 2
Table 3
Table 4
Downloads
Article
RIS [TXT - 2 KB]
Article Metrics
Metric Details
Author affiliations: Tel-Aviv University, Tel-Aviv, Israel (A. Lowenthal, H. Weisblum-Neuman, E. Birk, L. Ashkenazi-Hoffnung, I. Levy, H. Ben-Zvi, G. Amir, G. Frenkel, E. Bruckheimer, H. Yarden-Bilavsky, D. Marom, E. Shostak, E. Nahum, T. Dagan, G. Chodick, O. Scheuerman); Schneider Children’s Medical Center of Israel, Petach-Tikva, Israel (A. Lowenthal, H. Weisblum-Neuman, E. Birk, L. Ashkenazi-Hoffnung, I. Levy, G. Amir, G. Frenkel, E. Bruckheimer, H. Yarden-Bilavsky, E. Shostak, E. Nahum, T. Dagan, O. Scheuerman); Rabin Medical Center, Beilinson Hospital, Petach-Tikva (H. Ben-Zvi); Tel Aviv Sourasky Medical Center, Tel Aviv (D. Marom)

Cite This Article

Abstract

Kingella spp. have emerged as an important cause of invasive pediatric diseases. Data on Kingella infective endocarditis (KIE) in children are scarce. We compared the clinical features of pediatric KIE cases with those of Streptococcus species IE (StIE) and Staphylococcus aureus IE (SaIE). A total of 60 patients were included in the study. Throughout the study period, a rise in incidence of KIE was noted. KIE patients were significantly younger than those with StIE and SaIE, were predominately boys, and had higher temperature at admission, history of oral aphthae before IE diagnosis, and higher lymphocyte count (p<0.05). Pediatric KIE exhibits unique features compared with StIE and SaIE. Therefore, in young healthy children <36 months of age, especially boys, with or without a congenital heart defect, with a recent history of oral aphthae, and experiencing signs and symptoms compatible with endocarditis, Kingella should be suspected as the causative pathogen.

Infective endocarditis (IE) is a rare but potentially life-threatening disease in children and has an incidence of 0.8–3.3 cases/1,000 pediatric hospital admissions (1). Although early reports described IE exclusively in children whose hearts were structurally abnormal because of congenital heart disease or acquired rheumatic heart disease, this infection has more recently been reported in diverse groups of patients. In addition to children with congenital heart disease, other groups of children have emerged as being at high risk for IE, including children born prematurely; those with noncardiac congenital malformations, genetic syndromes, and malignancies; and, in particular, children with central venous catheters and those who have been treated by invasive procedures or intravenous medications (1–3).

The most common IE pathogens in children are gram-positive cocci, especially the α-hemolytic viridans group streptococci (e.g., Streptococcus sanguis, S. mitis group, and S. mutans), staphylococci, and enterococci. In patients with IE who are >1 year of age, the viridans group streptococci are the most commonly isolated organisms. Staphylococcus aureus is the second most common cause of IE in children but the most common cause of acute bacterial endocarditis (2). The HACEK group (Haemophilus parainfluenzae, H. aphrophilus, H. paraphrophilus, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella spp., and Kingella kingae) is a rare cause of IE, accounting for ≈1.4% of all cases of endocarditis (2,4).

Kingella spp. are carried asymptomatically in the oropharynx and disseminate through close interpersonal contact. These gram-negative bacteria (especially K. kingae) are commonly the etiology of pediatric bacteremia and the leading cause of osteomyelitis and septic arthritis in children 6–36 months of age (5). Invasive K. kingae disease usually affects previously healthy children <4 years of age, whereas older children and adults frequently have predisposing conditions (6).

Kingella IE (KIE) is estimated to account for 0%–6% of all IE cases in the general population (7–10). Similar numbers have been described in the pediatric population in a few published reports. Kingella appears to cause an even higher number of endocardial infections in children and was the etiologic agent of 4 (7.8%) of 51 episodes in a tertiary-care pediatric hospital in Israel (3) and of 6 (7.1%) of 85 cases among New Zealand children (11). However, lower rates of KIE have also been reported; a recent study of 53 cases of IE in Belgium described no cases of KIE (12). Serious cardiovascular and central nervous system complications and a need for emergent cardiac surgery for life-threatening complications that do not respond to conservative medical treatment have been described in the pediatric population (13). Kingella spp. as a causative pathogen of endocarditis has been poorly studied, and the number of studies regarding the pediatric population is limited (3,11,14–20). Therefore, we examined the characteristics of pediatric KIE case-patients to compare these cases with IE cases caused by other common pathogens.

Methods

We retrospectively reviewed all files of children with IE admitted to Schneider Children’s Medical Center of Israel (Petach-Tikva, Israel) during 1994–2019. We included children <18 years of age with history and physical findings consistent with possible or definite diagnosis of IE according to the Duke criteria (21). Culture-negative IE cases were excluded because some might represent undiagnosed KIE. We also excluded cases of endocarditis that were attributed to coagulase-negative staphylococci species and other rare enteric gram-negative bacteria, because these consist of only nosocomial cases or IE cases associated with foreign bodies or intravenous catheters, which are epidemiologically distinct from the general IE pediatric population. A pediatric cardiologist and a pediatric infectious diseases specialist reviewed all files. Cases were divided into 2 groups on the basis of bacterial etiology: KIE (K. kingae and K. dentrificans) and non-Kingella IE (non-KIE, including Streptococcus species and S. aureus).

Each isolate was identified by using the VITEK 2 system (bioMérieux, https://www.biomerieux.com) or MALDI Biotyper System (Bruker, https://www.bruker.com), in accordance with the manufacturers’ instructions for bacteria identification. Antimicrobial-susceptibility profiles of the isolates were determined by the disk diffusion method (Oxoid, http://www.oxoid.com), Etest (bioMérieux), or VITEK 2 as needed and interpreted based on the Clinical and Laboratory Standards Institute criteria for other non-Enterobacteriaceae (22). Data retrieved from patients’ charts included demographics, past medical history, clinical manifestations, laboratory findings, imaging studies, treatment, and outcome. The characteristics of KIE were compared with characteristics of Streptococcus species IE (StIE) and S. aureus IE (SaIE). The study was approved by the local institutional review board.

Statistical Analysis

To compare baseline correlates between case categories, we employed a χ2 test for categorical variables, analysis of variance test for parametric continuous data, and Kruskal–Wallis test for nonparametric continuous data. We calculated p values for the post hoc comparison with Bonferroni correction for the number of comparisons. Statistical analyses were performed by using SPSS Statistics 23.0 software (IBM, https://www.ibm.com) and the tableone package (23) in R version 3.6.1 (R Foundation for Statistical Computing, https://www.r-project.org).

Results

Study Population

During the study period, IE was diagnosed in 114 admitted patients, yielding an incidence rate of 1.4 cases/1,000 admissions. A total of 60 patients with IE caused by Kingella species, Streptococcus species, or S. aureus were included in this study. In 19 patients (14% of total IE admissions), the causative pathogen was Kingella species (K. kingae [n = 18] and K. dentrificans [n = 1]); in 25 patients (19%), the causative pathogen was Streptococcus species (S. viridans [n = 17], S. pneumoniae [n = 6], and S. pyogenes [n = 2]); and in 16 patients (12%), the causative pathogen was S. aureus.

Baseline Characteristics

The baseline characteristics of study participants with KIE and non-KIE are detailed in Table 1. Patients with KIE were significantly younger than those with non-KIE (16 + SD 10.29 months vs. 91 + SD 74.11 months; p<0.001). Although the difference was not statistically significant, congenital heart disease was previously diagnosed in fewer patients with KIE than in patients with non-KIE (53% vs. 78%; p = 0.09). Based on queries regarding a previous heart murmur, far fewer patients with KIE had a history of a known murmur than those with non-KIE (37% vs. 71%; p = 0.027). All KIE cases were community-acquired. No statistically significant differences were observed in previous noncardiac disease and previous interventions (surgery, cardiac catheterization, and dental procedures) between the groups. Median time (weeks) between prior cardiac catheterization to infection was shorter for the non-KIE group than the KIE group but was not statistically significant.

Clinical, Laboratory, and Imaging Characteristics

We compiled the clinical, laboratory, and imaging characteristics of case-patients with KIE compared with non-KIE case-patients (Table 2). Patients with KIE had significantly higher fever when first examined (40°C [range 39.45°C–40°C] vs. 39°C [range 38.6°C–39.8°C]; p = 0.003). No difference was observed in duration of febrile disease before admission. Hepatosplenomegaly was more common among non-KIE patients. Approximately a quarter of KIE patients reported previous oral aphthae, significantly more than those in the non-HIE group (5 patients vs. 0 patients; p = 0.003). No additional differences in clinical findings were noted.

The leukocyte count at admission differed significantly in lymphocyte counts: 4.27 K cells/mL (3.04) among KIE case-patients vs. 2.21 K cells/mL (1.81) in non-KIE case-patients (p = 0.002). Study groups approached significance (p = 0.055) in neutrophil–lymphocyte ratio; patients with KIE had the lowest ratio (4.7), whereas non-KIE patients had a higher ratio (10.7). No differences were observed in other parameters of the complete blood count or the level of inflammatory markers between the 2 groups. The number of positive cultures differed significantly between the 2 groups; most patients with KIE had 1–2 positive blood cultures, and none had >4 positive cultures, compared with an average of 4 in the non-KIE group (p<0.001). Days to blood-culture sterilization were fewer in the KIE group (2 days [2–3] vs. 3 days [2–5]; p = 0.017). The chest radiography or echocardiography findings did not exhibit differential features between the 2 groups.

Duke criteria findings are listed in Table 2. Only 37% of those patients with KIE versus 98% in the non-KIE group (p<0.001) fulfilled the Duke major clinical criterion blood culture component. However, blood-culture positivity as a minor clinical criterion was far more prevalent in the KIE group than the non-KIE group (11 patients [58] vs. 1 patient [2]; p<0.001).

A post hoc comparison of the 3 pathogen groups (Table 3) showed that KIE differed significantly from the StIE group in a few parameters. Previous diagnosis of a heart murmur (p = 0.027) and hepatosplenomegaly (p<0.001) were less prevalent in patients with KIE. The absolute leukocyte count was significantly higher in the KIE group than in the StIE group (p<0.005). KIE was significantly more likely to be community-acquired than SaIE (p<0.012). Absolute neutrophil count was significantly lower in the KIE group than the SaIE group (p<0.001).

Outcome

Complications and mortality rates are shown in Table 4. No statistically significant differences were found between case-patients with KIE and those with non-KIE. Urgent surgery <10 days after admission was more common in the KIE group but did not reach statistical significance. No deaths occurred in the KIE group, whereas the non-KIE group had an intrahospitalization death rate of 17%.

Discussion

In this study we described the distinct features of pediatric KIE in a large cohort. We found that pediatric patients with KIE have similar characteristics, enabling the suspicion of Kingella as a causative pathogen when patients seek care. KIE is community-acquired and occurs in children (mean age 16 months) who are experiencing hyperpyrexia and have no history of previous structural heart disease. A quarter of patients in this study had a history of oral aphthae. This finding is consistent with previous studies indicating that Kingella are often carried in the oropharynx of toddlers and that oral aphthae are the port of entry resulting in bacteremia (5,6).

Relative lymphocytosis was found to be significantly more prevalent in the KIE group than the non-KIE group (4.27 K leukocytes/mL vs. 2.21 K leukocytes/mL). This finding is probably because of the younger age of KIE case-patients. Children with KIE had fewer positive blood cultures and shorter duration of positive cultures. When examining the Duke criteria, we found that a minority of KIE case-patients fulfilled microbiologic major criteria compared with non-KIE case-patients. Because the infection was community-acquired in all patients with KIE and only about half had structural heart disease, in most cases only 1 culture was drawn, probably because of the low level of suspicion. This practice might explain why culture positivity as a minor criterion was far more prevalent in the KIE group than the non-KIE group (57.9% vs. 2.4%). We can therefore assume that, in most cases of KIE, the diagnosis was not clear at admission and that non-KIE pathogens require prolonged antimicrobial regimens for eradication.

A previous study in Israel suggests that the proportion of pediatric KIE cases in Israel is rising, from 4.2% of total IE cases during 1980–1991 to 14% during 1994–2019 (24), consistent with the findings in our study. This high proportion of KIE has not been described previously in other countries (15,25). A probable explanation is the improved detection of this fastidious bacterium, combined with the tertiary nature of our medical center. In addition, a higher prevalence of Kingella infection in Israel is a plausible explanation (5,6).

Data characterizing the course of disease and fatal outcomes were not very helpful in differentiating between the groups, apart from deaths noted only in the non-KIE cohort, which probably signify that most KIE case-patients were healthier before contracting IE. We discovered some similarities between the KIE group and the SaIE subgroup; however, larger numbers are needed to draw significant conclusions. The similar trends observed in these groups emphasize the high risk for major complications in KIE as observed in previous studies (16,26). For reasons unknown, KIE causes devastating damage to the valve tissue in some cases but not others. This range of severity is probably explained by the different Kingella strains, which cause varying clinical syndromes (27). Unfortunately, K. kingae isolates of the patients in our study were not kept in our laboratory for further genotyping. A recent study postulated that a certain major virulence factor of K. kingae RtxA, a toxin that belongs to the RTX (repeats in toxin) group of secreted pore-forming toxins, is found in some K. kingae strains and causes cellular death by pore formation (28). Of note, S. aureus–derived α-toxin, a pore-forming exotoxin, has also been implicated as a major cause of cardiac tissue damage in SaIE (29).

The limitations of our study include its retrospective data gathering and the relatively small cohort. We did not include cases of IE caused by coagulase-negative staphylococci and enteric gram-negative bacteria in the study. These pathogens cause only nosocomial and foreign body–associated endocarditis and occur in a distinct hospital-associated population. Including those bacteria would have biased this study by further emphasizing Kingella as a community-acquired cause of IE. We also excluded culture-negative cases of endocarditis because these could have included partially treated cases of Kingella endocarditis. An additional limitation is a selection bias of the population because our medical center is a tertiary-care center. Therefore, patients in whom endocarditis is diagnosed, patients with congenital heart disease, and patients with serious complications are referred to our center from other hospitals. Conversely, this bias is preserved in all 3 groups because most pediatric patients with IE are referred to a tertiary-care center.

In conclusion, this study shows that pediatric KIE has typical features compared with StIE and SaIE. Clinical cases of high fever in young healthy children (<36 months of age), especially boys, with or without congenital heart defects and with a recent history of oral aphthae should raise the suspicion for KIE.

Dr. Lowenthal is a staff pediatric cardiologist at Schneider Children’s Medical Center of Israel. His main research interests are fetal echocardiography, echocardiography, and acquired pediatric heart disease.

Top

References

  1. Day  MD, Gauvreau  K, Shulman  S, Newburger  JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009;119:865–70. DOIPubMedGoogle Scholar
  2. Ferrieri  P, Gewitz  MH, Gerber  MA, Newburger  JW, Dajani  AS, Shulman  ST, et al. Unique features of infective endocarditis in childhood. Pediatrics. 2002;109:931–43. DOIPubMedGoogle Scholar
  3. Marom  D, Levy  I, Gutwein  O, Birk  E, Ashkenazi  S. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J. 2011;30:585–8. DOIPubMedGoogle Scholar
  4. Chambers  ST, Murdoch  D, Morris  A, Holland  D, Pappas  P, Almela  M, et al.; International Collaboration on Endocarditis Prospective Cohort Study Investigators. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8:e63181. DOIPubMedGoogle Scholar
  5. Yagupsky  P. Kingella kingae: carriage, transmission, and disease. Clin Microbiol Rev. 2015;28:54–79. DOIPubMedGoogle Scholar
  6. Dubnov-Raz  G, Ephros  M, Garty  BZ, Schlesinger  Y, Maayan-Metzger  A, Hasson  J, et al. Invasive pediatric Kingella kingae Infections: a nationwide collaborative study. Pediatr Infect Dis J. 2010;29:639–43. DOIPubMedGoogle Scholar
  7. Berbari  EF, Cockerill  FR III, Steckelberg  JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532–42. DOIPubMedGoogle Scholar
  8. Chambers  ST, Murdoch  D, Morris  A, Holland  D, Pappas  P, Almela  M, et al.; International Collaboration on Endocarditis Prospective Cohort Study Investigators. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8:e63181. DOIPubMedGoogle Scholar
  9. Geraci  JE, Wilson  WR. Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc. 1982;57:145–8.PubMedGoogle Scholar
  10. Thekekara  AG, Denham  B, Duff  DF. Eleven year review of infective endocarditis. Ir Med J. 1994;87:80–2.PubMedGoogle Scholar
  11. Webb  R, Voss  L, Roberts  S, Hornung  T, Rumball  E, Lennon  D. Infective endocarditis in New Zealand children 1994-2012. Pediatr Infect Dis J. 2014;33:437–42. DOIPubMedGoogle Scholar
  12. Kelchtermans  J, Grossar  L, Eyskens  B, Cools  B, Roggen  M, Boshoff  D, et al. Clinical characteristics of infective endocarditis in children. Pediatr Infect Dis J. 2019;38:453–8. DOIPubMedGoogle Scholar
  13. Amir  G, Frenkel  G, Rotstein  A, Nachum  E, Bruckheimer  E, Lowenthal  A, et al. Urgent surgical treatment of aortic endocarditis in infants and children. Pediatr Cardiol. 2019;40:580–4. DOIPubMedGoogle Scholar
  14. Berkun  Y, Brand  A, Klar  A, Halperin  E, Hurvitz  H. Kingella kingae endocarditis and sepsis in an infant. Eur J Pediatr. 2004;163:687–8. DOIPubMedGoogle Scholar
  15. Brachlow  A, Chatterjee  A, Stamato  T. Endocarditis due to Kingella kingae: a patient report. Clin Pediatr (Phila). 2004;43:283–6. DOIPubMedGoogle Scholar
  16. Foster  MA, Walls  T. High rates of complications following Kingella kingae infective endocarditis in children: a case series and review of the literature. Pediatr Infect Dis J. 2014;33:785–6. DOIPubMedGoogle Scholar
  17. Martínez Olorón  P, Romero Ibarra  C, Torroba Álvarez  L, Pérez Ocón  A. [Kingella kingae endocarditis] [in Spanish]. An Pediatr (Barc). 2011;74:274–5. DOIPubMedGoogle Scholar
  18. Rabin  RL, Wong  P, Noonan  JA, Plumley  DD. Kingella kingae endocarditis in a child with a prosthetic aortic valve and bifurcation graft. Am J Dis Child. 1983;137:403–4.PubMedGoogle Scholar
  19. Rotstein  A, Konstantinov  IE, Penny  DJ. Kingella-infective endocarditis resulting in a perforated aortic root abscess and fistulous connection between the sinus of Valsalva and the left atrium in a child. Cardiol Young. 2010;20:332–3. DOIPubMedGoogle Scholar
  20. Youssef  D, Henaine  R, Di Filippo  S. Subtle bacterial endocarditis due to Kingella kingae in an infant: a case report. Cardiol Young. 2010;20:448–50. DOIPubMedGoogle Scholar
  21. Li  JS, Sexton  DJ, Mick  N, Nettles  R, Fowler  VG Jr, Ryan  T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8. DOIPubMedGoogle Scholar
  22. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 25th edition informational supplement (M100–S25). Wayne (PA): The Institute; 2015.
  23. Yoshida  K, Bohn  J. tableone-package: create “Table 1” to describe baseline characteristics [cited 2020 Jul 26]. https://rdrr.io/cran/tableone/man/tableone-package.html
  24. Marom  D, Birk  E, Ashkenazi  S. Trends in pediatric infective endocarditis in a tertiary pediatric center in Israel [in Hebrew]. Harefuah. 2012;151:464–8, 98, 97.
  25. Gupta  S, Sakhuja  A, McGrath  E, Asmar  B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Congenit Heart Dis. 2017;12:196–201. DOIPubMedGoogle Scholar
  26. Baddour  LM, Wilson  WR, Bayer  AS, Fowler  VG Jr, Tleyjeh  IM, Rybak  MJ, et al.; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86. DOIPubMedGoogle Scholar
  27. Amit  U, Porat  N, Basmaci  R, Bidet  P, Bonacorsi  S, Dagan  R, et al. Genotyping of invasive Kingella kingae isolates reveals predominant clones and association with specific clinical syndromes. Clin Infect Dis. 2012;55:1074–9. DOIPubMedGoogle Scholar
  28. Bárcena-Uribarri  I, Benz  R, Winterhalter  M, Zakharian  E, Balashova  N. Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members. Biochim Biophys Acta. 2015;1848:1536–44. DOIPubMedGoogle Scholar
  29. Hoerr  V, Franz  M, Pletz  MW, Diab  M, Niemann  S, Faber  C, et al. S. aureus endocarditis: Clinical aspects and experimental approaches. Int J Med Microbiol. 2018;308:640–52. DOIPubMedGoogle Scholar

Top

Tables

Top

Cite This Article

DOI: 10.3201/eid2703.203022

Original Publication Date: February 09, 2021

1These authors contributed equally to this article.

Table of Contents – Volume 27, Number 3—March 2021

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Oded Scheuerman, Schneider Children’s Medical Center of Israel, 14 Kaplan St, PO Box 559, Petach Tikva 49202, Israel

Send To

10000 character(s) remaining.

Top

Page created: January 21, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external